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Background and Objectives: Obesity is defined by World Health Organization (WHO) as a BMI value 
over 30 and is associated with an increased risk of colon cancer in many studies. Whether weight change 
during adulthood is related to risk of colon cancer is not clearly related to the risk of cancer. This study not 
only investigates the relationship between body size at different ages and colorectal cancer risks but also 
focuses on the effect of weight changes throughout the adult years as related to both  gender and stage of 
life.  
 
Design and analysis:  A prospective cohort of 15,008 cancer-free people is followed up 1989 through 2007. 
Cox proportional hazard regression models adjusted for life style risk factors were used to calculate hazard 
ratios and 95% confidence intervals of incident colorectal/colon cancer. Age standardized incidence and 
age adjusted risk ratios are compared to address the association between different categorization of BMI 
and colorectal cancers. Stratification by stage of life and by gender is conducted to evaluate effect 
modification by these factors. 
 
Results: People with higher BMI at baseline tend to have higher risk of colorectal cancer during almost 20 
years of follow up The risk of colon cancer for people with moderate weight gain between age 21 and study 
baseline is 1.35(95% CI is 0.91 to 1.99) compared to people with constant or lower weight gains. If the 
weight change occurred between age 21 and age 65, the hazard ratio is 1.45 (95%CI is 0.93 to 2.25). 
Hazard ratio of weight gain between age 21 and study baseline for men and women is 1.23(95% CI is 0.63 
to 2.41) and 1.16(95% CI is 0.65 to 2.07) respectively. 
 
Conclusion: The data from this study suggest that high BMI and high weight gain might increase the risk 
of colon but not rectal cancer. The life stage during which weight change is evaluated may modify the 
effect of weight change on risk of colon cancer. There is no significant effect modification of gender on the 
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Colorectal cancer is the third most common cancer and the third leading cause of cancer death in both men 
and women in the United States [1, 2]. The prevalence of obesity was reported to occur in more than one 
third (34.9%) of U.S adults in 2012. Body Mass Index (BMI) values over 30 kg/m2 are reported to occur in 
39.5% of middle age (40 to 59 year-old) adults, 30.3% of younger (20 to 39year-old) adults and 35.4% of 
older adults (over 60 years old) have BMI (body mass index) values over 30 kg/m2 [3]. This prevalence of 
obesity is reducing the duration of healthy life by up to 19 years and has shortened people’s life expectancy 
by up to eight years in the United States[4]. Medical expenditure for obesity has rise from $78.5 to $147 
million per year from 1998 to 2008 in the United States[5], including both inpatient and non-inpatient 
medical costs from diseases including cardiovascular disease, diabetes and cancers [6]. 
 
The association between obesity and cancers has been identified for a long time. Obesity has been found to 
contribute to approximately 20% of all cancer cases[7] and 14%  and 20% of all cancer deaths in men and 
women, respectively[8]. Epidemiologic evidence shows associations between obesity and a variety of 
cancer types [9-17]. Endometrial cancer is one of the cancers consistently related to obesity. Higher BMI 
contributes to increased incidence and mortality of endometrial cancer in a positive dose response 
manner[7, 18]. The association between obesity and breast cancer is dependent on hormone receptor status, 
hormone replacement therapy (HRT) use and menopausal status[19]. The association between obesity and 
prostate cancer depends on the stage of the cancer. While obesity is shown to be protective to localized 
prostate cancer, it is positively associated with advanced prostate cancer [20-23]. This observation of 
varying effects by stage for localized versus advanced cases has been hypothesized to be due to low 
androgen level[24]. 
 
The biological mechanisms of the obesity-cancer relationship have been most frequently proposed to relate 
to insulin resistance. In vivo, in vitro and epidemiological studies have all provided evidence for this 
hypothesis. Insulin increases lipid synthesis of fatty acid esters to triglycerides in human body[25]. Obese 
individuals develop insulin resistance in order to produce less body fat and maintain balance[26]. 
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Molecular biology indicates that the initial molecular signal for insulin involves activation of the insulin 
receptor tyrosine kinase, which results in phosphorylation of insulin receptor substrates (IRSs) on multiple 
tyrosine residues. These tyrosine residues act as docking sites of PI3K pathway. Obesity causes a signaling 
defect by increasing expression and activity of several protein tyrosine phosphatases (PTPs) which 
dephosphorylate and thus terminate signaling propagated through phosphorylation events[26]. In this way, 
insulin resistance is induced. Insulin resistance then causes beta-cell compensation. Increased insulin 
secretion finally increases synthesis of IGF-1which stimulates the proliferation of tumor cells lines [27]. 
Also, hyperglycemia provides a high glucose level, which supports the demands for tumor cell growth. 
Cytokines and adipokines may also play roles in the obesity-colon cancer relationship[24]. 
 
During the recent 30 years, multiple case-control studies [28-37] and prospective cohort studies[38-55] 
have consistently shown positive associations between BMI and colon cancer risks in men, but insignificant 
or  no association in women. The association does not include rectal cancer with most studies showing no 
association between BMI and rectal cancer risks in both men and women[29-31, 36, 42, 52, 55, 56]. A 
systematic review and meta-analysis in 2007 reported that obesity (BMI>30 kg/m2) is significantly 
associated with colorectal cancer when compared obese to normal body size (BMI<25 kg/m2) and this 
positive association is more significant among men than among women, and more significant in colon 
cancer than in rectal cancer[57]. Another systematic review and meta-analysis in 2007 summarized from 31 
prospective studies found a positive association between BMI/waist circumference/waist-hip ratio and 
colon cancer. These associations are significant among both men and women, though the association for 
women was weaker. That meta-analysis also found that BMI is positively associated with rectal cancer 
among men, but not in women [58].  
 
The discrepancy between men and women in terms of BMI and colon cancer risk might be due different 
body composition, postmenopausal hormone replacement therapy use (HRT), and parity. Men are  tend to 
have abdominal obesity while women are  tend to have lower body or gluteofemoral obesity[59]. Hormone 




A human’s weight changes during their lifespan but the dynamic influence of weight change on colorectal 
cancer is not fully understood. However, one way to look at it is to distinguish changes in the body size at 
middle life to body size at earlier adulthood and weight changes during that period[18]. Multiple studies 
have addressed this topic, but the association has not been clarified. 
 
Early adulthood obesity has been shown to increase the risk of colorectal cancer [50, 62-64]. However, 
observations are not consistent. Two studies [50, 62] showed higher BMI at adolescent (age range 15-19) 
significantly increases colorectal cancer incidence. Another study [64] showed higher BMI at 20 years old 
is statistically significantly associated with risk of distal colon cancer but not other colon or rectal cancer 
subtypes.  Three other [65-67] studies showed no association between BMI at age 18 or 20 and colon 
cancer risk. Han et al. [18] showed no association between BMI at age 25 and risk of incident colorectal 
cancer. Nimptsch et al. [63]showed in 2011 in Nurses’ Health Study II pictogram body shape at age 20 is 
not significantly associated with risk of distal colorectal adenoma.  
 
Between 2008 and 2014, nine case-control or prospective studies on the association between weight/BMI 
change and colorectal cancer were published [18, 64-71]. However, these studies relied on different weight 
change measures and reached inconsistent conclusions. The study design, exposure measures and results 
are summarized in Table 0. The earliest of those studies is a case-control study composed of colon cancer 
cases from Kentucky Cancer Registry[65] and controls from random digital dialing within State of 
Kentucky. The weight change measure in this study is the difference in BMI between age 20 and study 
baseline. Results show a 10kg/m2 increase in BMI is associated with 174% increased risk for women to 
develop colon cancer. (Odds ratio 2.74(95% CI= 1.27–5.92) ). An increase in BMI among men was not 
shown to be associated with colon cancer risk among men. 
 
Five of the studies [64, 66, 68, 70, 71] focused on absolute value of weight change in kilograms between 
young adult age and the study recruitment time or another time point. Among these five studies, the Health 
Professionals Follow-Up Study (HPFS)[71], the Melbourne Collaborative Cohort Study[66] and the 
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Norwegian Counties Study[70] showed significantly increased colon cancer risk for men with larger weight 
gain. Weight change measure in HPFS is the difference of weight values during each two-year follow-up 
cycle and the risk period of colon cancer onset was set to be the second or the third next two-year follow-up 
cycle in order to give a lag time of two to four years. The significant association between this weight 
change measure and colon cancer risk also suggests that short-term weight change before colon cancer may 
play a major role.  In the second study, weight change measure is the difference of weight in kilogram 
between study recruitment and age 18. In Norwegian Counties Study, the statistical significance only exists 
in men with BMI values over 25 at the study baseline. Netherlands Cohort Study [64] and EPIC [70] study 
suggested no significant association between this weight change measure and colon cancer risk in men. 
There is no association of absolute weight change in most of the studies for women [64, 66, 70] except 
EPIC study, where women did show a significant association between absolute weight change and colon 
cancer risk. 
 
In 2015, a systematic review and meta-analysis published in Journal of National Institute of Cancer [72] 
synthesized four of those studies using a linear dose-response. Each 5 kg of weight gain in men is 
associated with 9% increase of colon cancer risk (Relative Risk = 1.09 with 95% confidence interval of 
1.04 to 1.13,  I2 = 0.0%, Pheterogeneity = 0.76). The association is not significant in women. 
 
Three of the nine studies[67-69] defined the weight change as annual change in weight by kilograms. Their 
results are different from each other. The association for men is significant in NIH-AARP study and 
PANACEA study, but is not significant in EPIC. The association for women is significant in EPIC but not 
significant in NIH-AARP and PANACEA. 
 
Han et al.[18] described the association between percentage weight change and colorectal cancer in 
Atherosclerosis Risk in Communities (ARIC) study. Their study population consists of participants within 
a narrow age range between 45 and 64 and the results shows a 5% increased risk of colorectal cancer with 
every 5% increase in percent weight change between age 25 and study baseline (Hazard ratio is 1.05 (1.02–
1.07), adjusted for BMI at age 25 and lifestyle confounders for colorectal cancer). 
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A set of risk factors of colorectal cancer (CRC) has been reported in many studies. These factors include 
family history of CRC, education level, anti-diabetic medication use, cigarette smoking, alcohol 
assumption, red meat consumption and physical inactivity[73]. These factors might confound the 
association between weight change and colon cancer risk and are often adjusted in the Cox proportional 
hazard regression model in previous studies. 
 
CLUE II cohort study started at 1989 and is composed of male and female adult residents with a very wide 
age range between 18 and 94. This population could add information regarding the association between 
BMI at various ages ,, the roles of obesity at young adulthood and prediagnostic weight change from early 
adulthood to later years in the risk  of colorectal cancer and to compare which of these weight measures is 
more influential. The population also enables us to study the association between prediagnostic weight 
change and colorectal cancer risk by subsite of colon cancer, by different genders and at different stages of 
life during which weight change is defined. Through this investigation, we could better understand the roles 
gender and anatomic location may play and perhaps identify the most important stage of life in terms of 
risk of colon cancer from weight change. 
 
Therefore, the conclusions from this study could be useful in developing public health 
strategies for reducing the epidemic of obesity and its related risks of cancer by identifying at what age 
weight interventions are likely to have the greatest impact on the risk of the disease. This knowledge will 
help planners target population in which the greatest risk reduction might be achieved related to specific 
public health programs.  
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1Mean of all available information on current weight up to the beginning of each 2- year follow-up cycle, which we call the cumulative mean weight. This time-varying variable combined with height 
reported in 1986 was utilized to calculate cumulative mean BMI (kg/m2); 2weight change between 1986-1988 on risk of colon cancer 1990–92, weight change 1988–1990 on risk 1992–94, etc. 3weight 
change between age 21 and 1988 on risk of colon cancer 1990–92, weight change 21 years-1990 on risk 1992–94, etc. Weight change was calculated per 10 years to take account of different time 
periods from age 21 to age during follow-up. 4Sig stands for statistically significant effect measures comparing any categories; Nonsig stands for none of the association comparing any categories is 
statistically significant, but there might be some trend; Noassoc means no significant or pattern detected; 5♂ stands for male, ♀ stands for female; 6Criteria for BMI categorization is according to WHO 






CLUE II is a community-based population in Washington County, Maryland established for etiology 
research on cancer and cardiovascular diseases. During May and October of 1989, multiple mobile office 
trailers, covering all sections of the communities in Washington County, were stationed to take 
questionnaire surveys of demographic information, disease history and cancer-related life style 
characteristics. Both baseline questionnaires and blood samples were collected from 32,894 participants, 
which represents about 30% of the total Washington County adult population according to data from 1990 
Census. Among those participants, 7,818 were excluded for non-residency in Washington County; 5,470 
were excluded for ages less than 30 at baseline; 1,360 were excluded for prior history of cancer self-
reported in the questionnaires in 1989 and verified by Washington County Cancer Registry in 1990(people 
with non-melanoma skin cancer and carcinoma in situ were not excluded) at baseline; and 3,238 were 
excluded for non-response to the 1989 baseline Food Frequency Questionnaires. This eligibility screening 
left a study population of 15,008 people at baseline. 
Written informed consents were obtained from all CLUE II participants when the data collection 
questionnaire were filled out and the blood samples were taken. The CLUE II study was approved by the 
institutional review board (IRB) of Johns Hopkins School of Public Health (JHSPH). This masters’ thesis 
research is approved by IRB of JHSPH and the George W. Comstock Center for Public Health Research & 
Prevention. 
 
ASSESSMENT OF EXPOSURES AND OUTCOMES 
 
Self reported weight (unit: kilogram) and height (unit: centimeter) in the 1989 baseline questionnaires were 
used to calculate individual BMI at baseline as weight/height2 (unit: kg/m2). BMI at age 21 were self-
reported in the 1989 baseline data collection questionnaire. Weight change is defined as difference of body 
weight in kilograms between baseline at 1989 and age 21. Other cancer risk factors (cigarette smoking 
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status and years of education), population demographics (age, gender, residence status) and medication 
history (anti-diabetic medication use and hormone replacement therapy use in women) were also collected 
from the baseline data collection questionnaires. Red meat consumption includes intake of hamburger, 
beef, beef stew, pork, hot dog, ham/lunch meat, bacon, and sausage. The information is based on 13,276 
participants with responses from 1989 food frequency questionnaires. The family history of colorectal 
cancer among first-degree relatives is recorded from the first active follow up questionnaire conducted in 
1996. Physical activity level is ascertained from the second active follow-up survey in 1998. All the follow-
ups were self-administered through postal mail to the participants. Response rates in 1996 and 1998 were 
69.89% and 64.28% respectively. Many of theses variables have not been included in the final analyses. 
Diagnosis of primary CRC is defined as first primary occurrence of colon (International Statistical 
Classification of Diseases and Related Health Problems-8th /9th revision codes 153.0-153.9, or ICD-10th 
revision codes C18.0-C18.9 ) or rectal cancer (International Statistical Classification of Diseases and 
Related Health Problems-8th /9th revision codes 154.0 and 154.1, or ICD-10th revision, codes C19 and 
C20), or second primary occurrence of them if the first primary cancer was non-melanoma skin cancer or 
carcinoma in situ. The last CRC case in this study was obtained from the Washington County Cancer 
Registry on June 30th, 2007.  
Vital status and date of death were ascertained from linkage to National Death Index and Maryland death 
certificates. The last death in this study was detected on Sep 26th, 2008 
ANALYSIS 
 
STATA (version13.0, Stata Corporation, College Station, TX) is used in this study. Alpha is set to be 0.05 
as statistically significant. Descriptive characteristics are based on Chi-Square or Fisher exact test for 
categorical variables and ANOVA for continuous variables with normal distribution. BMI categorization is 
based on: 1) the International Classification weight grouping for adult Caucasians: underweight: <18.5; 
normal weight: >=18.5 and <25; overweight: >=25 and <30; obesity: >=30 [74]; 2) quartiles. Age 
standardized incidence rate is based on age distribution of the whole study population as the standard 
population. Weight change categorization is based on tertiles. 
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Cox proportional hazard regression model is used to calculate hazard ratio (HR) and the corresponding 
95% confidence interval (95%CI) for evaluation of colorectal cancer risks. Multivariate models are 
adjusted for confounders in the BMI-colon cancer causal pathway. These potential confounders include 
age, CRC family history in the first-degree relatives, cigarette smoking status, diabetic medication use, red 
meat consumption and physical activity level. They were identified according to literature[73]. Among 
these potential confounders, those included in the multivariate adjusted models are according to the criteria: 
1) significantly associated with the exposure; 2) are risk factors for the outcome (a priori from the 
literature); 3) not the mediator between the exposure and the outcome; 4) with missing rate<15%. Rectal 
cancer incidence is regarded as the competing risk event in the estimation for colon cancer risks and vice 
versa. Calendar year is used as the time metric in the primary analysis and age is used as the time metric in 
the sensitivity analysis. Baseline in 1989 is the entry of each individual and exit is the date of death, date of 
diagnosis of incidence of primary colorectal cancer or date of administrative censoring on June 30th 2007, 




Descriptive characteristics at baseline are summarized in Table 1. Based on WHO criteria, more than half 
(56.63%) of the adult residents of Washington County in this study population are overweight or obese. 
The average age of this study population at the study baseline at 1989 is 52.81. The proportions of obesity 
by gender indicated that 11.7% women and 25.06% of men were overweight or obese at age 21 and the 
proportions at baseline were 49.12% for women and 67.01% for men. Men are more likely to be 
overweight or obese than women at both early adulthood and middle age. The average BMI increased from 
22.08 at age 21 to 26.27 at baseline with 88% of the study population showing increased BMI between age 
21 and date of study baseline. 
 
The proportion of current smokers is 16.06% for women and 16.98% for men while the proportions for 
ever smokers are 39.11% and 60.47% for men and women respectively. These data indicate that men are 
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more likely to have smoked and also are more likely to have stopped before baseline. As shown from 
Table1, men with lower BMI and women with higher BMI are more likely to be smokers. This relationship 
between cigarette smoking and BMI are statistically significant in both genders. 
 
People with higher BMI are more likely to report use of anti-diabetic medication, to consume higher 
amounts of red meat and to have lower level of physical activity than persons with lower BMIs. These 
patterns are all significant and they exist in both men and women. People with normal BMI values have the 
highest proportion of college graduates and the lowest proportion of persons with no higher education. 
Obese and underweight women are less likely to take hormone replacement therapy compared to normal 
weight women. Family history of cancer is not associated with BMI at baseline for men and women.  
 
Among the total 15,008 eligible participants, 42.19% are men. The number of people with incident 
colorectal cancer onset during a 19.2 years of follow up (median follow up time is 17.96 years) was 247. 
The incidence rate for colorectal cancer was 0.10 per 100 person-year in this population. The total person-
time at risk is 243661.5.  
 
The upper left panel of Table 2 shows a suggestion of a positive dose-response relationship between BMI at 
baseline and risk of colorectal cancer. In the crude model, overweight and obese people show 1.12 and 1.13 
times of hazard of incident primary colorectal cancer, comparing to normal weighted people, with 95% 
confidence intervals of  (0.84, 1.47) and (0.79, 1.59). Although none of the effect estimates is statistically 
significant, the positive dose response relationship becomes stronger after adjusting for age at baseline and 
the set of confounders identified a priori. In this multivariate adjusted model, obese people have a 31% 
higher risk of developing colorectal cancer during the follow-up. The last column of the upper left panel of 
Table 2 shows the stratum-specific age standardized incidence rates of colorectal cancer. These incidence 
rates are weighted according to the age distribution of the whole population thus are age standardized and 
could be compared across the BMI strata. People with normal BMI have the lowest incidence rate. 
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The upper right panel shows the BMI measurements at age 21 and indicates a negative dose-response 
impact on colorectal cancer risk. This lower risk in overweight and obese could be due to its relationship 
with weight change between age 21 and baseline. The last column of this panel shows people with higher 
BMI at age 21 tend to gain less weight and this association is statistically significant. 
 
The two lower panels of Table 2 shows the associations based on BMI quartiles. The left panel shows the 
association between BMI quartiles and colorectal cancer risks. The reference group is people with BMI 
between 23.0 and 25.5 and the third quartile is based on BMI values between 25.5 and 28.6. There is no 
significant or clear pattern for this association and. The lower right panel of Table 2 shows the relationship 
between BMI at 21 and colon cancer risk, as well as the distribution of weight change across the strata of 
early adult BMI. The second quartile and third quartile of young adults have BMI values ranges 19.8-21.5 
and 21.5-23.7. These two strata shows similar hazard ratios. Higher BMI at age 21 decreases colon cancer 
risk, which is the same as the upper right panel. BMI at age 21 also shows a non-significant reverse 
relationship with weight change, just as that based on WHO guideline for body size classification for 
general Caucasian adults. 
 
Table 3 shows people in the second and the third tertiles of weight gain have higher risks of developing 
colorectal cancer compared to those in the first tertile of weight gain. Though not statistically significant, 
this effect is more obvious after adjusting for BMI at age 21 and more obvious for colon cancer than the 
combined group of colon and rectal cancers. In fact the effect is not shown in rectal cancer. After adjusting 
for BMI at age 21 and other confounders, people with the weight gain of 11.70 kg (standard 
deviation=2.57kg) are 26% more likely to develop colorectal cancer and 35% more likely to develop colon 
cancer, comparing to people in the first tertile of weight gain. People with an average weight gain of 
25.61kg (standard deviation = 8.47 kg) are 18% more likely to develop colorectal cancer and 24% more 
likely to develop colon cancer. For rectal cancer, a negative dose-response effect is shown, as larger weight 
gain results in higher risks of rectal cancer onset. Numbers of rectal cancer cases in the three weight gain 
tertiles are 12, 14 and 13.  
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Table 4 stratifies the population into two groups by people’s age at baseline. The two subgroups of 
participants enter the study at average ages of 41 and 65. Therefore, the life stage of weight gain we 
calculated in this study is different for these two subgroups of people. The results from Table 4 shows that 
if a person is at his younger life stage (age range between 30 and 52), either losing weight or gaining too 
much weight could increase his risk of developing colon cancer. The hazard ratio is 1.57 (95% confidence 
interval is 0.66 to 3.72) for people who lose weight during the earlier life stage and 1.11(95% confidence 
interval is 0.48 to2.56) for people who gain a larger amount of weight during the earlier life stage, 
comparing to those who gain a smaller amount of weight during the earlier life stage. In the other subgroup 
of people, who weight gain period is from age 21 to 65 (range: 53-94), the hazard ratio for the third tertile 
of weight gain is 1.31(95% confidence interval is 0.81 to 2.11) , which is less than that for the second 
tertile:1.27(95% confidence interval is 0.80 to 1.99).  
 
Table 5 shows the gender difference in association between weight gain and risk of colon cancer. For men, 
a larger weight gain is associated with higher risk of colon cancer, after adjusting for BMI at age 21 and all 
other confounders. Differently, women with the second highest tertile of weight gain are of the highest risk 
of incident colon caner (adjusted hazard ratio is 1.51, 95% confidence interval is (0.87, 2.61)), higher than 
women with highest tertile of weight gain (adjusted hazard ratio is 1.16, 95% confidence interval is (0.65, 
2.07)). 
 
In the sensitivity analysis, age was used as the time metric to test whether survival models are robust to this 
population. In this sensitivity analysis, age 0 is regarded as origin of time at risk; age at 1989 study 
recruitment is regarded as individual entry into the study. Everyone in this model is late entry. Hazard 
ratios gained from this model are comparing people with the same age at baseline. The results (not shown 
in this thesis) are consistent with that of the primary analysis.  
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Table 1.  Descriptive characteristics of study population by gender and BMI at baseline1 
 
1All factors except physical activity are at baseline; 2Based on 13276 participants with response from 1989 food frequency questionnaire, unit=serving per week; 3Based on 9202 participants 



























      n% 0.32 32.75 49.81 17.12  2.01 48.88 30.34 18.78  
      Age: mean(SD) 51.15(16.72) 53.0(14.44) 53.11(13.09) 51.12(12.38) 0.0003 56.40(16.37) 51.69(14.18) 55.01(13.27) 52.13(12.66) <0.0001 
      Smoking status <0.001     <0.001 
Never/% 45.00 41.13 38.87 38.87  55.17 60.24 60.94 63.11  
Former/% 20.00 39.73 45.66 44.23  14.94 21.53 24.92 24.86  
Current/% 35.00 19.14 15.47 16.90  29.89 18.23 14.13 12.03  
      Diabetic medication <0.001     <0.001 
 Yes/% 0.00 2.27 3.36 5.26  1.15 1.18 3.42 7.37  
No/% 100.00 97.73 96.64 94.74  98.85 98.82 96.58 92.63  
      Education <0.001     <0.001 
No higher edu/% 30.00 16.92 21.49 20.61  22.41 16.04 25.02 29.12  
Some higher/% 55.00 69.33 67.69 68.15  70.11 75.34 69.73 66.89  
College graduate or 
above/% 
15.00 13.74 10.82 11.24  7.47 8.62 5.25 3.99  
      Cancer Family history 0.666     0.059 
 No 14.29 35.52 35.29 34.43  36.73 28.23 25.99 26.64  
Yes 85.71 64.48 64.71 65.57  63.27 71.77 74.01 73.36  
      Red meat2 14.57(25.49) 6.72(5.94) 7.29(5.97) 5.87(6.50) <0.0001 4.90(4.11) 4.85(3.51) 5.28(3.90) 6.16(5.00) <0.0001 
      Physical Activity3 0.003     <0.001 
Low/% 20 31.46 35.68 40.61  31.25 29.60 33.75 40.80  
Medium/% 40 37.25 37.30 35.49  28.12 38.13 36.43 37.59  
High/% 40 31.30 27.01 23.89  40.62 32.27 29.82 21.61  
      Hormone replacement therapy use for females      <0.001 
Never % NA NA NA NA NA 86.75 83.58 83.27 87.61  
Former % NA NA NA NA NA 6.63 3.78 4.39 3.72  
Ever % NA NA NA NA NA 6.63 12.64 12.34 8.66  
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Table 2. Association between BMI measures, weight change and colorectal cancer risk1 



























































































P-value  >0.05 >0.05  Ptrend  >0.05 >0.05 <0.001 
 
 



























































































P-value  >0.05 >0.05  Ptrend  >0.05 >0.05 <0.001 
 
1Time metric is calendar time in the Cox regression model for hazard ratios 
2Mutivariate models adjusted for age at baseline, education, cigarette smoking status and red meat consumption 














CRC Colon Rectal 
No. 
CRC/person-
























for BMI at 211 
T1 1.18(6.00) 75/91106.36 1.00(ref) 1.00(ref) 63 1.00(ref) 1.00(ref) 12 1.00(ref) 1.00(ref) 
T2 11.70(2.57) 94/81230.05 1.23(0.87, 1.74) 1.26(0.89, 1.79) 80 1.33(0.91, 1.94) 1.35(0.91, 1.99) 14 0.87(0.38, 1.99) 0.93(0.41, 2.13) 
T3 25.61(8.47) 77/70852.52 1.14(0.79, 1.63) 1.18(0.81, 1.72) 64 1.22(0.82, 1.82) 1.24(0.82, 1.88) 13 0.85(0.36, 1.99) 0.94(0.40, 2.18) 
























Younger life stage weight change 
--Age 21 to 41 (range: 30-52) 
Middle life stage weight change 

































BMI at age 212 













































P-value <0.001 <0.032  >0.05 >0.05 <0.001 <0.001  >0.05 >0.05 
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Weight Change  
(95% CI)1 
Weight Change 
Adjusted for BMI at 21 
(95% CI)1 
T1 1.26 (6.55) 27 1.00(ref) 1.00(ref) 
T2 11.80(2.52) 26 1.08(0.61, 1.92)  1.03(0.57, 1.87) 











Weight Change  
(95% CI)2 
Weight Change 
Adjusted for BMI at 21 
(95% CI) 2 
T1 1.17(5.56) 31 1.00(ref) 1.00(ref) 
T2 11.63(2.61) 59 1.45(0.85, 2.48) 1.51(0.87, 2.61) 
T3 25.87(8.69) 31 1.11(0.62, 1.98) 1.16(0.65, 2.07) 
1Mutivariate models adjusted for education, cigarette smoking status and red meat consumption; 2adjusted for education, cigarette 




BMI at baseline suggests a possible association with risk of colorectal cancer. BMI at age 21 suggests a 
negative association with risk of colorectal cancer. People in the intermediate level of weight gain seem to 
have the highest increase in the risk of colon cancer. This pattern is not shown in rectal cancer. Weight gain 
at different ages in one’s life may influence people’s future colon cancer risk differently and the association 




In this study, higher BMI at age 21 is not significantly and shows a negative relationship with future colon 
cancer risk, which is consistent with previous findings[18, 65-67]. . This negative pattern could be due to 
the close association between BMI at age 21 and weight change from age 21to baseline for this study. In 
this population, people with higher BMI at age 21 are less likely to gain much weight perhaps because 
weight tends to plateau at higher weights. Larger weight gain from age 21 to study baseline leads to a 
higher risk of colorectal cancer incidence. The effect size becomes larger when adjusting for weight at age 
21 in addition to all other confounding risk factors. This means BMI at age 21 influenced the effect of 
weight change moving the risk toward the null.  
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The body size classification used in most studies is based on WHO guidelines for adults[74], and is used in 
this study for both BMI at baseline and BMI at age 21. However, the body size categorization for the adult 
population and for people at young adulthood who are aged 21 may not be entirely similar. Therefore, we 
conducted the analysis of associations based on quartiles of BMI values. The result based on BMI quartiles 
at age 21 shows that the second and the third stratum are very close in terms of the risk of future colon 
cancer. Persons within the lowest BMI stratum show a slightly increased risk and those within the highest 
stratum shows slightly decreased risk. These findings suggest that young people at age 21 who fall within 
the middle 75% of the BMI distribution have no difference risk in colon cancer onset in later life. However, 
if the young person has a BMI in the lowest or the highest quartiles of the population, he or she will have 
increased or decreased risk of colon cancer, respectively. This observation could be due to differences in 
the magnitude of weight gain as they age with thinner young adults more likely to gain weight later in life 
and higher possibility for heavier young adults to control weight gain later in life.  
 
Table 3 shows the differences in the risk of weight gain by cancer site, with colon cancer risk increasing 
with weight gain and rectal cancer suggesting a pattern of decreasing risk with increasing weight gain This 
is consistent with results from multiple studies[67, 68]. 
 
This study shows people with highest weight gain during middle life stage will have increased risk of colon 
cancer comparing to the reference group and this finding may not occur for weight gain at younger ages. If 
this is correct the data suggest that a person may not increase their risk of colon cancer with moderate 
weight gain during ages 21 to 41 but may increase their risk at older from weight gain at older ages. Life 
stage may modify effects of weight change. This trend might suggest that moderate weight gain before 41 
years is not harmful unless this weight gain continued through the next 20 years of life. Older people (aged 
53 and above at study baseline) with the highest tertile of weight gain shows less high colon cancer risk 
than those with the middle tertile of weight gain. This could be influenced by the fact that the average age 
of persons in the highest weight gain stratum is younger than ages of the middle stratum and age is an 
influential risk factor in colon cancer development[73].  
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The risk of colon cancer for men and women shows no significant difference. In both genders, increasing 
weight is associated with a higher risk of colon cancer. However the pattern is less clear in women than in 
men. An explanation for this observation could be that additional factors in women play a role in colon 
cancer development that are not adjusted for in this study. It is also possible that further research may 
identify differences in the role of accrual of fat in women than in men, because there are biological 
differences between men and women, which are important predictors of colon cancer risk. 
 
One of the limitations of this study is its lack of statistical significance. Patterns are detected but none of 
them are statistically significant. This population of 15,008 participants with 247 colorectal cancer cases 
does not have enough power to detect statistically significant associations. A solution to this problem is to 
combine other populations together for analysis or update the cancer outcome surveillance to 2014.  
 
Another limitation of this study is the response rate. The missing rates of cigarette smoking status, diabetic 
medication use, hormone replacement therapy (HRT) use and education are less than 4%. However, the 
variable for red meat consumption is missing in 15% and for physical activity for 38.7% of the population. 
This makes it difficult to adjust for these variables because of loss of population. In the multivariate 
adjusted models, current and former smokers and people with diabetic medication, HRT, higher red meat 
consumption and lower level of education are associated with higher risk. The associations are not 
significant.  Physical activity is not included in the model because of the missing rate.  
 
The third limitation is the variety in the age period of weight change. In the sensitivity analysis, age at 
baseline is shown to have dramatic impact on the risk estimates. The primary analysis based on a time 
metric of age is able to compare the risk among people with the same age at baseline. In the primary 
analysis stratified to two subgroups by age at baseline, differences in the effects are noted. In order to get 
better effect estimates, a larger sample size compose of people with smaller range of age is needed. 
 
The current study has been unable to demonstrate statistically significant results for many of the observed 
patterns of change. However, the observations suggest that future research should focus more on the effect 
 19 
of weight change during different periods of life. Longitudinal repeated measurements and the potential of 
adding biological measurements should be proposed. Methods to handle missing data must be included in 
any such study. In summary, it remains to be seen at what age weight interventions are 
likely to have the greatest impact, which is a significant issue in selecting 
appropriate populations for specific public health strategies. Equally important will 
be the addition of use and development of biological measures that may better identify 
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six subclasses or with double robust estimate (Relative hazard=1.01909(0.9046, 1.1480) and 
1.0092(0.8961, 1.1366)) 
 Advisors: Alison Abraham 
 
 Medical Interventions for Primary Open Angle Glaucoma Network Meta-Analysis      2014 
 Advisors: Tianjing Li, Kay Dickersin 
 Responsibilities: 
. Manuscript preparation 
. Title/abstract/full text screening for meta-analyses for clinical trials on eye diseases;  
. Data abstraction, recording and discrepancies adjudication using Systematic Review 
Data Repository (SRDR) data system 
 
 Intrastromal corneal ring segments for treating keratoconus                      
2014 
 Advisors: Tianjing Li, Kay Dickersin, Kristina Lindsley 
 Responsibilities: 
. Manuscript preparation 
. Title/abstract/full text screening for meta-analyses for clinical trials on eye diseases;  
. Data abstraction, recording and discrepancies adjudication using Systematic Review 
Data Repository (SRDR) data system 
 
PUBLIC HEALTH EXPERIENCE    
Data abstractor                                       05/2014 to 
08/2014 
International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health 
•  Data Abstraction 
                                                                                                                                  
Public Health Administrator       
 07/2012~08/2012 
Nanjing Health Supervision State at Qinhuai District 
•  Assisted in issuing of health administrative licenses 
 
Physician Assistant/Surgeon Assistant                  
02/2011~01/2012 
Yixing People’s Hospital 
•  Assisted in surgeries, performed physical examinations, wrote and maintained medical records, interacted 
with and comforted patients, developed key medical skills 
 
Public Health Administrator       
 07/2010~07/2010  
Jiangsu Provincial Center for Disease Control  
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•  Collected data about the situation of iodine deficiency diseases (IDD) in Jiangsu Province 
•  Assisted in voluntary counseling and testing program for homosexual men 
 
VOLUNTEER  ACTIVITIES                                                                                                                                 
Volunteer          
 12/2011~08/2013  
The Second Youth Olympic Games/The Second Asian Youth Games 
•  Participated overall preparations for games: oral interpretation for visitors and maintenance of YOG website   
Vice President         
 11/2008~03/2010  
Wind Orchestra of Nanjing Medical University 
•  Coordinated rehearsals and logistics for orchestra and performed at several universities   
Peer educator          
 11/2008~01/2009  
The Red Ribbon Peer Association 
•  Hosted AIDS Peer Education among college students 
 
AWARD AND HONORS  
•  BSPH Masters Tuition Scholarship for Academic Year 2014-2015 
•  Excellent Student Scholarship for Academic Year 2008-2009, 2009-2010 and 2010-2011 
•  Best Student Leader Award for the Year of 2008, 2009 and 2010 
•  Innovation Scholarship for Academic Year 2009-2010 
•  Shanghai Interpretation Accreditation (SIA)(gained in Nov 2010) 
•  Third Prize in National English Contest for College Students (gained in May 2010)  
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